Abstract #0725

Phase II Clinical Hyperpolarized 13C 3D-Dynamic Metabolic Imaging of Prostate Cancer using a B1-insensitive Variable Flip Angle Design

Hsin-Yu Chen^1,2, Peder E.Z. Larson^1,2, Jeremy W. Gordon¹, Robert A. Bok¹, Marcus Ferrone³, Mark van Criekinge¹, Lucas Carvajal¹, Rahul Aggarwal⁴, James B. Slater¹, Ilwoo Park¹, Eugene Milshteyn^1,2, Sarah J. Nelson^1,2, John Kurhanewicz^1,2, and Daniel B. Vigneron^1,2

¹Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, United States, ²UCSF/UC Berkeley Graduate Program in Bioengineering, University of California, San Francisco, San Francisco, CA, United States, ³Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, CA, United States, ⁴School of Medicine, University of California, San Francisco, San Francisco, CA, United States

The 3D compressed-sensing echo-planar spectroscopic imaging (CS-EPSI) sequence has enabled 5-dimensional HP-¹³C imaging of human prostate cancer with full-prostate coverage and high spatial and temporal resolution. A new variable flip angle design substantially desensitizes the sequence to B₁ variations for improved quantitative analysis of pyruvate-to-lactate rate constant (k_PL) measurements. Pre-clinical animal and clinical patient studies demonstrate that the resulting sequence enabled improved quantitative accuracy while maintaining excellent metabolite SNR.

This abstract and the presentation materials are available to members only; a login is required.

Join Here